QSI QUANTUM-SI INC

Quantum-Si to Participate in Upcoming Investment Conferences

BRANFORD, Conn.--(BUSINESS WIRE)--

(Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.

On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under .

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at or follow us on or .

EN
05/11/2024

Underlying

QSIQUANTUM-SI INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on QUANTUM-SI INC

 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si Highlights Major Technical Advances, Next-Generation Platfo...

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024. Quantum-Si’s Management team announced Platinum™ Pro, the Company’s evolution of Platinum, as well as Proteus™, the Company’s new cutting-edge proteomics platform of the future, that is now under development. “We are very excited to have this opportunity to unveil the rapid innovation that we have achieved at Quantum-Si over the ...

November 21, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™...

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in the U.S. and Canada streamlined access to these innovative proteomics solutions. The distribution agreement enables Avanto...

November 20, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si to Develop Acceleration Platform and Advance Core Technolog...

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing. This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leveraging NVIDIA accelerated computing and Quantum-Si’s advanced single-molecule protein sequencing and detection technologies,...

November 20, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Pro...

BRANFORD, Conn. & BLOOMINGTON, Minn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si’s next-generation platform designed to transform proteomic research. The expanded collaboration will develop the consumable for Proteus that will enable simultaneous large factor, protein sequencing with unparalleled accuracy. Quantum-Si and SkyWater began par...

November 20, 2024 1 EN
 PRESS RELEASE
Free
QSI QUANTUM-SI INC

Quantum-Si and Planet Innovation to Partner on Proteus™

BRANFORD, Conn.--(BUSINESS WIRE)-- (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si’s novel proteomics platform, Proteus™. Planet Innovation has a team of over four hundred people with expertise across design, development and manufacturing of scientific instrumentation and medical devices. Currently, Planet Innovation serves as the contract manufacturer for Quantum-Si’s Platinum® Pro instrument, set to debut in the first half of 2025. Through ...

November 20, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch